Inovio Pharmaceuticals, Inc. (INO) Posts Q2 Loss of 3c/Share
Inovio Pharmaceuticals, Inc. (NYSE: INO) reported Q2 EPS of ($0.03) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
